Triple A therapy: The molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide-Reference-Cited by-同舟云学术

Triple A therapy: The molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide

Published:2014-03 Issue:1 Volume:27 Page:19-31
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Nichol Jessica N.,Garnier Nicolas,Miller Wilson H.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference124 articles.

1. The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?;Ablain;Cancer Discov,2011

2. Role of the WT1 tumor suppressor in murine hematopoiesis;Alberta;Blood,2003

3. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair;Alcalay;J Clin Invest,2003

4. Mitochondrial metabolism of reactive oxygen species;Andreyev;Biochemistry,2005

5. Introduction: the history of arsenic trioxide in cancer therapy;Antman;Oncologist,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiation Therapy;Holland‐Frei Cancer Medicine;2022-10-21

2. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia;Anti-Cancer Drugs;2020-02

3. Chemosensitive augmentation effect by combination treatment of vorinostat and arsenic trioxide in U266 cell line;Journal of Microbiology & Experimentation;2018-03-28

4. ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia;Nucleic Acids Research;2018-03-15

5. Epistaxis, Ecchymoses, and an Abnormal White Blood Cell Count;JAMA;2017-07-25